KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Work In Process: 2018-2019

Historic Work In Process for Amneal Pharmaceuticals (AMRX) over the last 2 years, with Dec 2019 value amounting to $58.2 million.

  • Amneal Pharmaceuticals' Work In Process was N/A to $53.1 million in Q1 2020 from the same period last year, while for Mar 2020 it was $53.1 million, marking a year-over-year change of. This contributed to the annual value of $58.2 million for FY2019, which is 7.45% up from last year.
  • As of FY2019, Amneal Pharmaceuticals' Work In Process stood at $58.2 million, which was up 7.45% from $54.2 million recorded in FY2018.
  • Amneal Pharmaceuticals' Work In Process' 5-year high stood at $58.2 million during FY2019, with a 5-year trough of $54.2 million in FY2018.
  • In the last 2 years, Amneal Pharmaceuticals' Work In Process had a median value of $56.2 million in 2018 and averaged $56.2 million.
  • Data for Amneal Pharmaceuticals' Work In Process shows a peak YoY grew of 7.45% (in 2019) over the last 5 years.
  • Yearly analysis of 2 years shows Amneal Pharmaceuticals' Work In Process stood at $54.2 million in 2018, then increased by 7.45% to $58.2 million in 2019.